PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 2026Insights into Imaging0 citationsOpen Access

Predicting Aggressiveness and Prognosis in Cholangiocarcinoma Using MRI

The value of gadobenate dimeglumine-enhanced MRI quantification in predicting aggressiveness and prognosis of typical intrahepatic mass-forming cholangiocarcinoma: a multicenter retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

ZSZhang StBKBing KangCQChenyang Qiu

Discussion

Loading...

Member takes

Overview

Retrospective study predicts tumor aggressiveness and survival outcomes in cholangiocarcinoma, indicating MRI's potential value.

Key Points

  • The aim is to evaluate MRI's effectiveness in predicting the aggressiveness and prognosis of intrahepatic cholangiocarcinoma.
  • Multicenter retrospective study design
  • Used MRI quantification with gadobenate dimeglumine
  • Analyzed metrics like volume ratio and CA19-9 levels
  • Assessed relationships between imaging findings and survival outcomes
  • Volume ratio and relative intensity ratio are strong predictors of tumor aggressiveness.
  • CA19-9 levels ≥ 34 U/mL associated with poorer survival rates.
  • Tumor boundary features linked to decreased overall survival.
  • Maximum tumor size ≥ 3 cm correlated with shorter disease-free survival.

Cite This Study

St et al. (2026) studied this question.

synapsesocial.com/papers/69a91db5d6127c7a504c0c1dhttps://doi.org/10.1186/s13244-026-02225-4
View Full Paper
Ask AI
Bookmark
Share